Entrada Therapeutics Inc (TRDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 79,743 | 227,648 | 45,157 | 53,311 | 90,867 |
| Marketable Securities | 297,046 | 183,983 | 143,555 | 162,261 | 153,387 |
| Receivables | 3,744 | 6,297 | N/A | N/A | N/A |
| TOTAL | $390,195 | $434,135 | $209,875 | $234,733 | $253,903 |
| Non-Current Assets | |||||
| PPE Net | 11,018 | 9,394 | 7,681 | 7,444 | 7,785 |
| Other Non-Current Assets | 92,770 | 32,040 | 34,500 | 32,286 | 34,229 |
| TOTAL | $103,788 | $41,434 | $42,181 | $39,730 | $42,014 |
| Total Assets | $493,983 | $475,569 | $252,056 | $274,463 | $295,917 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,422 | 6,474 | 5,990 | 1,341 | 4,622 |
| Accrued Expenses | 7,105 | 11,676 | 7,576 | 11,951 | 5,341 |
| TOTAL | $125,940 | $147,594 | $21,972 | $21,551 | $18,077 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 101,645 | 122,341 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 65,624 | 9,122 | 17,530 | 19,692 | 21,801 |
| TOTAL | $161,135 | $98,363 | $17,530 | $19,692 | $21,801 |
| Total Liabilities | $287,075 | $245,957 | $39,502 | $41,243 | $39,878 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 33,271 | 33,197 | 33,076 | 31,406 | 31,368 |
| Common Shares | 3 | 3 | 3 | 3 | 3 |
| Retained earnings | -220,887 | -194,959 | -188,285 | -163,656 | -138,519 |
| Other shareholders' equity | -1,005 | -642 | -2,057 | -2,747 | -2,265 |
| TOTAL | $206,908 | $229,612 | $212,554 | $233,220 | $256,039 |
| Total Liabilities And Equity | $493,983 | $475,569 | $252,056 | $274,463 | $295,917 |